Statins and Mortality in COPD: A Methodological Review of Observational Studies

Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program

(2022) Ying-Yi Chen et al.   Journal of Personalized Medicine

Can Simvastatin reduce COPD Exacerbations? A Randomised Double Blind Controlled Study

(2021) Peter Schenk et al.   EUROPEAN RESPIRATORY JOURNAL

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study

(2021) Mathias Damkjær et al.   International Journal of Chronic Obstructive Pulmonary Disease

Effectiveness of Aspirin in COPD: Biases in the Observational Studies

(2021) Anirudh Bakshi et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink

(2021) Margaret C Smith et al.   BMJ Open

Time‐related biases in pharmacoepidemiology

(2020) Samy Suissa et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?

(2019) Samy Suissa   EUROPEAN RESPIRATORY JOURNAL

Handling time varying confounding in observational research

(2017) Mohammad Ali Mansournia et al.   BMJ-British Medical Journal

Handling time varying confounding in observational research

(2017) Mohammad Ali Mansournia et al.   BMJ-British Medical Journal

PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement

(2016) Jessie McGowan et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Real-World Evidence — What Is It and What Can It Tell Us?

(2016) Rachel E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores

(2016) Samy Suissa et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Lipid Profile and Statin Use: The Paradox of Survival After Acute Exacerbation of Chronic Obstructive Pulmonary Disease

(2015) Oren Fruchter et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction

(2015) M. Di Martino et al.   BMJ Open

Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD

(2014) Gerard J. Criner et al.   NEW ENGLAND JOURNAL OF MEDICINE

In-Hospital and One-Year Mortality and Their Predictors in Patients Hospitalized for First-Ever Chronic Obstructive Pulmonary Disease Exacerbations: A Nationwide Population-Based Study

(2014) Te-Wei Ho et al.   PLoS One

Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease

(2013) Magnus P. Ekström et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial

(2013) Seyed Ali Javad Moosavi et al.   Iranian Red Crescent Medical Journal

Effect of Statins on Total Cholesterol Concentrations, Cardiovascular Morbidity, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study

(2012) Xia Sheng et al.   CLINICAL THERAPEUTICS

Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

(2012) Alvar Agustí et al.   PLoS One

Statins, systemic inflammation and risk of death in COPD: The Rotterdam study

(2012) Lies Lahousse et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality

(2012) Samy Suissa et al.   THORAX

Statin use in COPD patients is associated with a reduction in mortality: a national cohort study

(2012) Carlene MM Lawes et al.   Primary Care Respiratory Journal

A New Criterion for Confounder Selection

(2011) Tyler J. VanderWeele et al.   BIOMETRICS

Statin Use and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Cohort Study in Taiwan

(2011) Chin-Chou Huang et al.   CLINICAL THERAPEUTICS

Statins and outcome after hospitalization for COPD exacerbation: A prospective study

(2011) Konstantinos Bartziokas et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Co-Morbidity in COPD: The Effects of Cardiovascular Drug Therapies

(2010) Samy Suissa   RESPIRATION

Statins in COPD

(2009) Surinder Janda et al.   CHEST

Statin Adherence and Risk of Accidents

(2009) Colin R. Dormuth et al.   CIRCULATION

Illustrating bias due to conditioning on a collider

(2009) Stephen R Cole et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Associations between statins and COPD: a systematic review

(2009) Claudia C Dobler et al.   BMC Pulmonary Medicine

Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study

(2008) A. I. Blamoun et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Immortal Time Bias in Pharmacoepidemiology

(2007) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY

Confounding: What it is and how to deal with it

(2007) K.J. Jager et al.   KIDNEY INTERNATIONAL